Development and Evaluation of the Biological Adjuvant Bivalent Vaccine for Preventing Newcastle Disease and Infectious Bursal Disease

Figure 1

The rescue of the recombinant viruses. The titration of rClone30-VP2L-chGM-CSF and rClone30-VP2L was performed by HA.